BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Duke-NUS Secures €2 Million EU Grant to Expand Wastewater Surveillance Across Asia

EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge Duke-NUS Medical School h...

June 11, 2026 | News

Waters Launches Coin Cell DSC to Advance Battery Safety Testing and Thermal Analysis

Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whol...

June 11, 2026 | News

PromptBio Launches Agentic AI Platform to Accelerate Scientific Discovery

The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PromptBio, a Californ...

June 11, 2026 | News

Formation Bio Doses First Participant in Phase I Trial of Lynk’s CNS-Penetrant TYK2 Inhibitor

Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseas...

June 12, 2026 | News

Can the 'Pharmacy of the World' Survive Its Own Scandals?

In late September and early October 2025, children in the central Indian state of Madhya Pradesh began arriving at hospitals with the same grim trajectory:...

June 08, 2026 | Analysis

Pierre Fabre Laboratories Receives CHMP Positive Opinion For BRAFTOVI Combination In First Line BRAF Mutant Metastatic Colorectal Cancer

This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination w...

May 27, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

May 26, 2026 | News

Hyundai Bioscience Positions XAFTY As Potential Ebola And Hantavirus Treatment Following Strong IC50 Findings

Ebola IC50 (0.125μM)—Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM). Clinical safety confi...

May 22, 2026 | News

KBP Biosciences Says Singapore Court Made No Fraud Finding In Ongoing Novo Nordisk Arbitration

KBP Biosciences Pte. Ltd. issued a statement addressing the decision by the Singapore Court of Appeal to maintain the temporary injunction against the Comp...

May 22, 2026 | News

CHEPLAPHARM Group Advances AI Ready Supply Chain Transformation Through TraceLink Network Integration

The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration TraceLink, the world...

May 18, 2026 | News

SN BioScience Inc. Initiates Global Phase 1b/2 Trial Of SNB 101 In Extensive Stage Small Cell Lung Cancer

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its...

May 18, 2026 | News

Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical productio...

May 05, 2026 | News

WuXi Biologics Advances Chengdu Microbial Manufacturing Site Toward GMP Production

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the structural completion and k...

April 27, 2026 | News

WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturin...

April 24, 2026 | News

Stay Connected